Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma
 | Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma CME, CPE Alison J. Moskowitz, MD | |
| Release Date: September 10, 2018 Expiration Date: September 10, 2019 | ||
| The management of patients with newly diagnosed Hodgkin lymphoma (HL) continues to evolve as new therapies and treatment approaches are being investigated and introduced. This activity will review helpful, evidence-based strategies for individualizing therapy in the frontline setting by describing emerging treatment regimens for newly diagnosed HL and the latest clinical data regarding these options. Provided by MediCom Worldwide, Inc. This activity is supported by educational grants from Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics, Inc. | ||
| View Only, CE ExpiredView Only, No Credit | ||